Multicenter, retrospective, 12 month study of Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat (Stribild) in a Spanish Region in HIV-infected patients

Trial Profile

Multicenter, retrospective, 12 month study of Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat (Stribild) in a Spanish Region in HIV-infected patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2016

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top